Notícias Janux Therapeutics Inc - JANX | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Janux Therapeutics Inc (JANX)
Janux Therapeutics Inc (JANX) Notícias

Janux Therapeutics Inc (JANX)

48,00

-0,82

(-1,68%)

Fechado 27 Novembro 6:00PM

Atrasado por 15 minutos

48,00

0,03

(0,06%)

Após o horário de negociação: 6:00PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Janux Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições